Abstract The Asia–Pacific Working Group on Inflammatory Bowel Disease was established
in Cebu, Philippines, under the auspices of the Asia–Pacific Association of Gastroenterology …

The incidence of Crohn disease (CD) has been increasing and surgery needs to be
contemplated in a substantial number of cases. The relevant advent of biological treatment …

Background While mucosal healing has been proved to predict relevant clinical outcomes in
Crohn's disease (CD), little is known about the long‐term significance of transmural healing …

Background Transmural healing (TH) of Crohn's disease (CD) is a still unexplored and
interesting outcome correlated to concept of deep remission. Aim To assess the rate of TH in …

AIM To systematically review the literature on epidemiology, disease burden, and treatment
outcomes for Crohn's disease (CD) patients with complex perianal fistulas. METHODS …

Perianal disease is one of the most disabling manifestations of Crohn's disease. A
multidisciplinary approach of gastroenterologist, colorectal surgeon and radiologist is …

The biologic antitumor necrosis factor alpha (anti-TNFα) agents have revolutionised the
treatment of inflammatory bowel disease (IBD). However, some patients experience primary …

Objective. Treatment with tumour necrosis factor antagonists (anti-TNF) has been
recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of …

Spondyloarthritis (SpA) is a group of diseases with similar clinical, radiologic and serologic
features, including SpA associated with inflammatory bowel disease (IBD-associated SpA) …

The management of moderate to severe ulcerative colitis has undergone significant
changes over the past 15 years due to the regulatory approval of several new drugs. In …